AHL
ABUS icon

Abel Hall LLC’s Arbutus Biopharma ABUS Stock Holding History

Abel Hall LLC’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.8K Sell
18,300
-1,773
-9% -$7.79K 0.02% 852
2026
Q1 		$90.3K Sell
20,073
-10,706
-35% -$46.8K 0.02% 699
2025
Q4 		$148K Buy
+30,779
New +$138K 0.03% 581

Other funds holding ABUS

LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return
WMA
Wealth Management Associates Cherry Hill, New Jersey $362M AUM 33.28% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PPWP
Premier Path Wealth Partners Madison, New Jersey $870M AUM 30% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Abel Hall LLC's ABUS Position: Q2 2026 in Review

Abel Hall LLC reduced its Arbutus Biopharma (ABUS) stake by 8.8% in Q2 2026, selling an estimated $7.79K and leaving 18,300 shares worth $87.8K. The position accounts for 0.02% of the portfolio, ranked #852.

Abel Hall LLC first reported a position in ABUS in Q4 2025 and has held it in 3 quarters since. The position peaked at $148K in Q4 2025. 19 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Abel Hall LLC held 18,300 shares of Arbutus Biopharma worth $87.8K as of Q2 2026.
  • Abel Hall LLC sold 1,773 Arbutus Biopharma shares in Q2 2026, an estimated $7.79K.
  • Arbutus Biopharma made up 0.02% of Abel Hall LLC's portfolio in Q2 2026, its #852 holding.
  • Abel Hall LLC first reported a position in Arbutus Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Arbutus Biopharma position peaked at $148K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.